Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Sep-Oct;30(5):289-98.
doi: 10.1097/HCR.0b013e3181d6f9a8.

The treatment of obesity in cardiac rehabilitation

Affiliations
Review

The treatment of obesity in cardiac rehabilitation

Philip A Ades et al. J Cardiopulm Rehabil Prev. 2010 Sep-Oct.

Abstract

Obesity is an independent risk factor for the development of coronary heart disease (CHD). At entry into cardiac rehabilitation (CR), more than 80% of patients are overweight and more than 50% have the metabolic syndrome. Yet, CR programs do not generally include weight loss programs as a programmatic component and weight loss outcomes in CR have been abysmal. A recently published study outlines a template for weight reduction based on a combination of behavioral weight loss counseling and an approach to exercise that maximized exercise-related caloric expenditure. This approach to exercise optimally includes walking as the primary exercise modality and eventually requires almost daily longer-distance exercise to maximize caloric expenditure. In addition, lifestyle activities such as stair climbing and avoidance of energy-saving devices should be incorporated into the daily routine. Risk factor benefits of weight loss and exercise training in overweight CHD patients are broad and compelling. Improvements in insulin resistance, lipid profiles, blood pressure, clotting abnormalities, endothelial-dependent vasodilatory capacity, and measures of inflammation such as C-reactive protein have all been demonstrated. Cardiac rehabilitation/secondary prevention programs can no longer ignore the challenge of obesity management in CHD patients. Individual programs need to develop clinically effective and culturally sensitive approaches to weight control. Finally, multicenter randomized clinical trials of weight loss in CHD patients with assessment of long-term clinical outcomes need to be performed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The Energy Balance Equation. In a steady state situation, energy intake would equal energy expenditure.
Figure 2
Figure 2
Quintiles of Physical Activity by Accelerometer (Kcal/day) vs. Weight Loss (r = 0.64, P<.0001).
Figure 3
Figure 3
Components of total daily energy expenditure by group, before and after weight loss and exercise. aP<.05 within group for physical activity energy expenditure. bP<.05 change pre-post between groups for physical activity energy expenditure.
Figure 4
Figure 4
Weight loss by group at 5 and 12 months (with permission, American Heart Association). *P<.05 vs. baseline. †P<.05 vs. change in standard cardiac rehabilitation group.

References

    1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295:1549–1555. - PubMed
    1. Ades PA, Savage PD, Brawner CA, et al. Aerobic capacity in patients entering cardiac rehabilitation. Circulation. 2006;113:2706–2712. - PubMed
    1. Bader DS, Maguire TE, Spahn CM, O’Malley CJ, Balady GJ. Clinical profile and outcomes of obese patients in cardiac rehabilitation stratified according to National Heart, Lung, and Blood Institute criteria. J Cardiopulm Rehabil. 2001;21:210–217. - PubMed
    1. Audelin MC, Savage PD, Ades PA. Changing clinical profile of patients entering cardiac rehabilitation/secondary prevention programs: 1996 to 2006. J Cardiopulm Rehabil Prev. 2008;28:299–306. - PubMed
    1. Ross R, Dagnone D, Jones PJ, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med. 2000;133:92–103. - PubMed

Publication types

Substances